自我管理的穴位按摩治疗抑郁症 (SAAFD)
抑郁症的自我指压按摩：一项随机对照试验
The goal of this clinical trial is to examine the effects of self-administered acupressure intervention for alleviating depressive symptoms among people with depression. It is hypothesized that the self-administered acupressure group would have a great improvement in depressive symptoms as measured by the Patient Health Questionnaire compared with the mental health education group across the 12-week intervention period.
The main questions it aims to answer are:
- Is the self-administered acupressure intervention more effective for alleviating depression and other related outcomes compared to the mental health education group among depressed individuals?
- Is the self-administered acupressure intervention acceptable and feasible for depressed individuals to alleviate depression? Participants will be randomized into self-administered acupressure group or mental health education group based on the group allocation with a 1:1 ratio. Participants will attend two weekly 120-min self-administered acupressure training or mental health education, respectively.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Hong Kong、香港
- School of Nursing, the Hong Kong Polytechnic University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Hong Kong residents aged 18 to 65
- Can communicate in Cantonese and comprehend written Chinese
- Have moderate or above-level depression as measured by the PHQ-9 with a score of 10 or above
- Willing to give informed consent and comply with the trial protocol.
Exclusion Criteria:
- Have the PHQ score of 20 or above (referral information to community psychological services will be provided)
- New onset or change of antidepressant medication or dosage in the last 3 months
- Previous or current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder as screened using the Chinese version of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders.
- Have cognitive impairment diagnosed by the Hong Kong Montreal Cognitive Assessment with a score < 22
- Skin lesions or infections at the treatment sites
- Significant suicidal risk as rated by the Hamilton Depression Rating Scale item on suicide (score ≥3)
- Pregnant or childbearing potential but not using adequate contraception
- With any major medical condition that causes depression based on the judgement of a psychiatrist.
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Self-administered acupressure group
The participants in the self-administered acupressure group will attend an acupressure training course (2 sessions, 2 h each) to learn self-administered acupressure from an acupuncturist in a classroom at the School Nursing, the Hong Kong Polytechnic University. Each class will be conducted in a small group of 4 to 7 participants to enhance interaction and ensure the quality of teaching. Participants will then practice two times a day for 8 weeks. |
Self-administered acupressure treatment group was developed on the basis of previous systematic reviews and clinical studies of acupuncture and acupressure for depression. It has robust theoretical basis of TCM. The acupoints selected are commonly used for depression according to a recent systematic review and recommended by other clinical practice guidelines. |
|
有源比较器：Mental health education group
The participants in the comparison group will receive mental health education group from a registered nurse with the same frequency as those in the treatment group (2 sessions, 2 h each) in a classroom at the School Nursing, the Hong Kong Polytechnic University, and will be reminded to follow the mental health practice daily for 8 weeks. |
Mental health education training group was developed based on the materials regarding depression and mental health from the Centre of Health Protection, Department of Health, the Government of Hong Kong SAR and reviewed by a clinical psychologist. |
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Patient Health Questionnaire (PHQ)
大体时间：It will be measured at baseline
|
The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. |
It will be measured at baseline
|
|
Patient Health Questionnaire (PHQ)
大体时间：It will be measured at week 4 from baseline
|
The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. |
It will be measured at week 4 from baseline
|
|
Patient Health Questionnaire (PHQ)
大体时间：It will be measured at week 8 from baseline
|
The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. |
It will be measured at week 8 from baseline
|
|
Patient Health Questionnaire (PHQ)
大体时间：It will be measured at week 12 from baseline
|
The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. |
It will be measured at week 12 from baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Hamilton Depression Rating Scale (HDRS)
大体时间：It will be measured at baseline
|
The HDRS is used to assess the severity of depressive symptoms based on the 17-item scale. Eight items are scored on a 5-point scale, ranging from 0 to 4 and nine items are scored from 0 to 2. The total score varies from 0 (the minimum value) to 52 (the maximum value), with a higher total score indicating more severe depression. |
It will be measured at baseline
|
|
Hamilton Depression Rating Scale (HDRS)
大体时间：It will be measured at week 4 from baseline
|
The HDRS is used to assess the severity of depressive symptoms based on the 17-item scale. Eight items are scored on a 5-point scale, ranging from 0 to 4 and nine items are scored from 0 to 2. The total score varies from 0 (the minimum value) to 52 (the maximum value), with a higher total score indicating more severe depression. |
It will be measured at week 4 from baseline
|
|
Hamilton Depression Rating Scale (HDRS)
大体时间：It will be measured at week 8 from baseline
|
The HDRS is used to assess the severity of depressive symptoms based on the 17-item scale. Eight items are scored on a 5-point scale, ranging from 0 to 4 and nine items are scored from 0 to 2. The total score varies from 0 (the minimum value) to 52 (the maximum value), with a higher total score indicating more severe depression. |
It will be measured at week 8 from baseline
|
|
Hamilton Depression Rating Scale (HDRS)
大体时间：It will be measured at week 12 from baseline
|
The HDRS is used to assess the severity of depressive symptoms based on the 17-item scale. Eight items are scored on a 5-point scale, ranging from 0 to 4 and nine items are scored from 0 to 2. The total score varies from 0 (the minimum value) to 52 (the maximum value), with a higher total score indicating more severe depression. |
It will be measured at week 12 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Stress
大体时间：It will be measured at baseline
|
The DASS-21 Stress subscale will be used to measure the emotional states of stress using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Stress
大体时间：It will be measured at week 4 from baseline
|
The DASS-21 Stress subscale will be used to measure the emotional states of stress using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 4 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Stress
大体时间：It will be measured at week 8 from baseline
|
The DASS-21 Stress subscale will be used to measure the emotional states of stress using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 8 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Stress
大体时间：It will be measured at week 12 from baseline
|
The DASS-21 Stress subscale will be used to measure the emotional states of stress using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 12 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Anxiety
大体时间：It will be measured at baseline
|
The DASS-21 Anxiety subscale will be used to measure the emotional states of anxiety using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Anxiety
大体时间：It will be measured at week 4 from baseline
|
The DASS-21 Anxiety subscale will be used to measure the emotional states of anxiety using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 4 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Anxiety
大体时间：It will be measured at week 8 from baseline
|
The DASS-21 Anxiety subscale will be used to measure the emotional states of anxiety using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 8 from baseline
|
|
The Depression Anxiety Stress Scales (DASS-21) - Anxiety
大体时间：It will be measured at week 12 from baseline
|
The DASS-21 Anxiety subscale will be used to measure the emotional states of anxiety using a 4-point scale ranging from 0 (never) to 3 (almost always). |
It will be measured at week 12 from baseline
|
|
The Insomnia Severity Index (ISI)
大体时间：It will be measured at baseline
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. |
It will be measured at baseline
|
|
The Insomnia Severity Index (ISI)
大体时间：It will be measured at week 4 from baseline
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. |
It will be measured at week 4 from baseline
|
|
The Insomnia Severity Index (ISI)
大体时间：It will be measured at week 8 from baseline
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. |
It will be measured at week 8 from baseline
|
|
The Insomnia Severity Index (ISI)
大体时间：It will be measured at week 12 from baseline
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. |
It will be measured at week 12 from baseline
|
|
The Short-Form (six-dimension) Health Survey (SF-6D)
大体时间：It will be measured at baseline
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. |
It will be measured at baseline
|
|
The Short-Form (six-dimension) Health Survey (SF-6D)
大体时间：It will be measured at week 4 from baseline
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. |
It will be measured at week 4 from baseline
|
|
The Short-Form (six-dimension) Health Survey (SF-6D)
大体时间：It will be measured at week 8 from baseline
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. |
It will be measured at week 8 from baseline
|
|
The Short-Form (six-dimension) Health Survey (SF-6D)
大体时间：It will be measured at week 12 from baseline
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. |
It will be measured at week 12 from baseline
|
合作者和调查者
调查人员
- 首席研究员：Wing Fai Yeung, PhD、the School of Nursing, the Hong Kong Polytechnic University
出版物和有用的链接
一般刊物
- Zhang Z, Li S, Meng H, Wang Y, Zhang Y, Wu M, Chen Y, Rong P, Wang Y. Efficacy and safety of acupuncture in the treatment of depression: A systematic review of clinical research. Anat Rec (Hoboken). 2021 Nov;304(11):2436-2453. doi: 10.1002/ar.24783. Epub 2021 Oct 8.
- Fernandez-Chinguel JE, Goicochea-Lugo S, Villarreal-Zegarra D, Taype-Rondan A, Zafra-Tanaka JH. Acupuncture for major depressive disorder: A review of the recommendations stated at clinical practice guidelines. Complement Ther Med. 2020 Mar;49:102321. doi: 10.1016/j.ctim.2020.102321. Epub 2020 Jan 24.
- Cheung DST, Tiwari A, Yeung WF, Yu DSF, So MKP, Chau PH, Wang XM, Lum TYS, Yuk Fung HYK, Ng BYM, Zhang ZJ, Lao L. Self-Administered Acupressure for Caregivers of Older Family Members: A Randomized Controlled Trial. J Am Geriatr Soc. 2020 Jun;68(6):1193-1201. doi: 10.1111/jgs.16357. Epub 2020 Feb 25.
- Kroenke K. Enhancing the clinical utility of depression screening. CMAJ. 2012 Feb 21;184(3):281-2. doi: 10.1503/cmaj.112004. Epub 2012 Jan 9. No abstract available.
- Yeung WF, Yu BYM, Ho FY, Wong CKH, Chung KF, Ruan JY, Chen S, Cheung DST, Zhang ZJ, Zick S, Cheng H, Ho YS, Ho LM, Lao L. Self-administered acupressure training for depression in community-dwelling individuals: a randomized controlled trial and cost-effectiveness analysis. EClinicalMedicine. 2026 Jun 16;96:104023. doi: 10.1016/j.eclinm.2026.104023. eCollection 2026 Jun.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- SelfAcupDep
- 19200171 (其他赠款/资助编号：Health and Medical Research Fund)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
The individual participant data will be available when the study has been published. The individual participant data will be available upon request.
IPD 共享时间框架
No time restriction for the data availability.
IPD 共享访问标准
The individual participant data will be available upon request.
IPD 共享支持信息类型
- 研究方案
- 树液
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.